https://doi.org/10.1038/s41421-023-00595-3
C
Chao Yu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
55
Papers
693
Citations
14
h-index
24
i10-index
Chao Yu is an academic researcher from Nanchang University. The author has contributed to research in topics: Epigenetics and DNA Methylation & Gout, Hyperuricemia, Uric Acid & Liver Disease Diagnosis and Treatment. The author has an h-index of 14, co-authored 47 publications.
ORCID: 0000-0002-6929-6693Papers by this author
worksMetformin potentiates nephrotoxicity by promoting NETosis in response to renal ferroptosis
2023 · Cell Discovery · 53 citations
Hypoxia-mediated SUMOylation of FADD exacerbates endothelial cell injury via the RIPK1-RIPK3-MLKL signaling axis
2025 · Cell Death and Disease · 13 citations
https://doi.org/10.1038/s41419-025-07441-2
Circular RNA APP contributes to Alzheimer’s disease pathogenesis by modulating microglial polarization via miR-1906/CLIC1 axis
2025 · Alzheimer s Research & Therapy · 10 citations
https://doi.org/10.1186/s13195-025-01698-7
Decoding the fatty liver-hyperuricemia link in the obese and nonobese hypertensive patients: insights from a cohort study
2024 · Scientific Reports · 1 citations
https://doi.org/10.1038/s41598-024-80895-0
The impact of angiotensin-receptor neprilysin inhibitors on cardiovascular events and solute transport function in peritoneal dialysis patients: a multicenter retrospective controlled study
2024 · Renal Failure · 1 citations
https://doi.org/10.1080/0886022x.2024.2431637
Genetic depletion or pharmacological degradation of EZH2 attenuates renal fibrosis via suppressing Notch signaling
2025 · Clinical Epigenetics · 1 citations
https://doi.org/10.1186/s13148-025-02013-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat